In particular, Δ16HER2, expressed in all HER2+ human BC, is formed following the excision of exon 16, resulting in the loss of a small juxtamembrane region of the receptor and the gain of the ability to form constitutively active homodimers. The gene discussed is ERBB2; the disease is breast cancer.